Cell-Based Reparative Therapies for Multiple Sclerosis
Authors:
- 29 September 2013
- journal article
- review article
- Published by Springer Nature in Current Neurology and Neuroscience Reports
- Vol. 13 (11) , 1-7
Abstract
The strong rationale for cell-based therapy in multiple sclerosis is based on the ability of stem and precursor cells of neural and mesenchymal origin to attenuate neuroinflammation, to facilitate endogenous repair processes, and to participate directly in remyelination, if directed towards a myelin-forming fate. However, there are still major gaps in knowledge regarding induction of repair in chronic multiple sclerosis lesions, and whether transplanted cells can overcome the multiple environmental inhibitory factors which underlie the failure of endogenous repair. Major challenges in clinical translation include the determination of the optimal cellular platform, the route of cell delivery, and candidate patients for treatment.Keywords
This publication has 68 references indexed in Scilit:
- Human iPSC-Derived Oligodendrocyte Progenitor Cells Can Myelinate and Rescue a Mouse Model of Congenital HypomyelinationCell Stem Cell, 2013
- Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis modelsNature Neuroscience, 2012
- Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept studyThe Lancet Neurology, 2012
- Th17 Cells Induce Ectopic Lymphoid Follicles in Central Nervous System Tissue InflammationImmunity, 2011
- The great migration of bone marrow-derived stem cells toward the ischemic brain: Therapeutic implications for stroke and other neurological disordersProgress in Neurobiology, 2011
- Cellular Therapy and Induced Neuronal Replacement for Huntington's DiseaseNeurotherapeutics, 2011
- Neural precursors exhibit distinctly different patterns of cell migration upon transplantation during either the acute or chronic phase of EAE: A serial MR imaging studyMagnetic Resonance in Medicine, 2011
- Safety and Immunological Effects of Mesenchymal Stem Cell Transplantation in Patients With Multiple Sclerosis and Amyotrophic Lateral SclerosisArchives of Neurology, 2010
- Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2Proceedings of the National Academy of Sciences, 2010
- Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitisGlia, 2002